Latest / Research To Practice | Oncology Videos
Hematologic Oncology | What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors
Featuring perspectives from Dr Nicole Lamanna and Dr William G Wierda, including the following topics:
Introduction: Mentoring Fellows (0:00)
Case: A woman in her mid 50s with multiple cardiovascular comorbidities and relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) receives bendamustine/rituximab induction followed by venetoclax/rituximab consolidation in a clinical trial — Spencer Henick Bachow, MD (11:47)
Case: A man in his late 70s with relapsed del(11q) CLL develops atrial fibrillation while receiving ibrutinib — Warren S Brenner, MD (18:15)
Case: A man in his early 70s with…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.